Aktuellt
SENASTE
Redeye provides a research update on Lipum following the Q4 report published by the company earlier today. We make some slight adjustments to our overall estimates following a revision of our model. However, we reiterate our previous fair value range (SEK5 – SEK35) with a base case valuation of SEK22 as we continue to see substantial upside potential in the stock.
LÄS MER
